Authorized generic Flomax
Executive Summary
Ranbaxy will launch tamsulosin capsules (generic Flomax) in March 2010 under an agreement with Astellas/Boehringer Ingelheim settling patent litigation, the generic firm announces Nov. 8. The settlement allows Ranbaxy to introduce a generic version of the treatment for benign prostatic hyperplasia prior to the expiration of pediatric exclusivity for Flomax, assuming it is granted by FDA. During the period of exclusivity, Ranbaxy will be the only generic firm in the market with the product. The firm's ANDA received tentative approval in June...